Content about Anti-diabetic drugs

April 19, 2013
FDA grants tentative approval to two Sun generics

The Food and Drug Administration has given tentative approval to two generic diabetes drugs made by Sun Pharmaceutical Industries, the Indian drug maker said.

March 22, 2013
Novo Nordisk drug produces significant weight loss in study

A drug made by Novo Nordisk for Type 2 diabetes produced a 6% loss of weight in a trial of the drug in obese patients, the company said.

January 21, 2013
GSK submits approval application for albiglutide

Drug maker GlaxoSmithKline is seeking Food and Drug Administration approval for a new treatment for Type 2 diabetes, the drug maker said.

August 9, 2012
Bristol-Myers Squibb, AstraZeneca expand diabetes deal

AstraZeneca paid $3.2 billion to Amylin Pharmaceuticals Thursday following the latter's acquisition by Bristol-Myers Squibb, AstraZeneca and Bristol said.

August 8, 2012
Bristol-Myers Squibb purchase of Amylin mostly complete, company says

Bristol-Myers Squibb has bought a majority stake in drug maker Amylin Pharmaceuticals, Bristol said Wednesday.

July 2, 2012
Bristol-Myers Squibb buys Amylin for $5.3 billion

Bristol-Myers Squibb is acquiring Amylin Pharmaceuticals, the drug maker said Friday.

June 14, 2012
Walgreens: Educating patients with diabetes on insulin injection improves adherence

A new Walgreens study released Thursday found that a pharmacist-led training and counseling program for patients receiving an injectable diabetes medication improved medication adherence by 24%.

June 12, 2012
Global study reveals correlation between insulin dosing irregularities, hypoglycemia

One-quarter of Type 2 diabetes patients do not take basal insulin as prescribed, while more than one-third suffer from hypoglycemia, according to a global survey funded by Novo Nordisk.

June 11, 2012
Analyses demonstrate efficacy of Symlin in Type 1, Type 2 diabetes patients

When one of Amylin Pharmaceuticals' diabetes drugs is used with mealtime insulin, both Type 1 and Type 2 diabetes patients maintain blood sugar in the normal glucose range on a daily basis, according to two analyses presented at the 72nd Scientific Sessions of the American Diabetes Association.

June 11, 2012
Study: Insulin degludec reduces risk of nocturnal hypoglycemia among Type 2 diabetes patients

An investigational insulin being developed by Novo Nordisk significantly reduced the rate of hypoglycemia at night in adults with Type 2 diabetes, according to results of a late-stage clinical trial presented at the 72nd Scientific Sessions of the American Diabetes Association.

May 22, 2012
BD introduces syringe with smaller needle for diabetes patients

Medical supply manufacturer BD has released a syringe with a shorter needle designed to reduce discomfort in patients with diabetes who must inject insulin, the company said Tuesday.

April 19, 2012
Watson seeks approval for generic Type 2 diabetes drug

Generic drug maker Watson is challenging the patent protection on a drug used to treat Type 2 diabetes.

April 9, 2012
FDA approves labeling change for Novo Nordisk diabetes drug

The Food and Drug Administration has approved a change to the label of a Novo Nordisk drug stating that it offers superior blood-sugar control to a competing drug made by Merck, based on results of two clinical studies, Novo Nordisk said Monday.

April 3, 2012
Amylin seeks FDA approval for metreleptin

Drug maker Amylin Pharmaceuticals has filed for regulatory approval of a drug to treat diabetes and elevated triglycerides in the bloodstream in children and adults with a rare disorder.

April 2, 2012
FDA OKs Levemir for pregnant women

A diabetes treatment made by Novo Nordisk is safe for pregnant women, according to a recent decision by the Food and Drug Administration.

April 2, 2012
Metformin may help slow progression, reduce risk of certain cancers

A medication commonly prescribed for patients with Type 2 diabetes also may play a critical role in patients at risk of developing certain cancers.

March 29, 2012
Study suggests metformin may help prevent heart disease

A commonly prescribed diabetes drug also may have the capability of protecting the heart, according to a Swedish study.

March 26, 2012
Report: Metformin cost-effective strategy in battling diabetes

Lifestyle intervention and treatment with metformin provide safe, long-term, cost-effective means of preventing Type 2 diabetes and should be incorporated into prevention strategies for reducing the dramatic rise in incidence of Type 2 diabetes in the United States, according to two new analyses and an editorial published in the April issue of Diabetes Care.

March 26, 2012
ReportersNotebook — Chain Pharmacy, 4/2/12

A drug under development by Forest Labs and Pierre Fabre has been shown to reduce symptoms of major depressive disorder, the companies said.

March 13, 2012
Pfizer, Biocon end biosimilar insulin deal

Pfizer and Indian drug maker Biocon have ended a partnership that the companies started in 2010 to develop biosimilar treatments for diabetes, the companies said.

March 8, 2012
Bydureon takes on diabetes

The market for drugs to treat diabetes — especially Type 2 diabetes — has shown quite a bit of activity lately.

March 7, 2012
Diabetes drug from Lilly, BI hits shelves

A new drug for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim is available in pharmacies, the companies said Wednesday.

February 13, 2012
Bydureon officially hits market

Amylin Pharmaceuticals and Alkermes announced that their Type 2 diabetes treatment now is available by prescription in U.S. pharmacies.

February 3, 2012
New diabetes drug launches show primary care market still strong

For all the fears about the patent cliff, at least one disease state seems to be on the up-and-up in terms of new drug development and new products.

February 3, 2012
Survey: Endocrinologists would prescribe Bydureon for 20% of patients

Endocrinologists would prescribe a newly approved weekly treatment for Type 2 diabetes to one-fifth of their patients, a new survey showed.

© 2013 Drug Store News. All Rights Reserved.